| |
| |
| Exchange: |
N/A |
| Security
Type: |
N/A |
| Shares
Out: |
70,010,000 |
| Market
Cap: |
N/A |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$23.99 - $23.99 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Drug Manufacturers - Major |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-01-14 |
2023-10-13 |
2023-04-14 |
2022-04-14 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Lovejoy Chandra D |
VP of Regulatory Affairs |
• – – |
2012-12-26 |
4 |
AS |
$9.05 |
$19,991 |
D/D |
(2,209) |
0 |
|
- |
|
| Lovejoy Chandra D |
VP of Regulatory Affairs |
• – – |
2012-12-26 |
4 |
OE |
$2.54 |
$5,611 |
D/D |
2,209 |
2,102 |
|
- |
|
| Ritter Allen R |
VP of Manufacturing/CMC |
• – – |
2012-12-18 |
4 |
AS |
$9.65 |
$19,300 |
D/D |
(2,000) |
4,983 |
|
- |
|
| Sanderling Ventures Management Vi |
10% Owner |
– – • |
2012-12-11 |
4 |
D |
$0.00 |
$0 |
I/I |
(182,947) |
0 |
|
- |
|
| Ritter Allen R |
VP of Manufacturing/CMC |
• – – |
2012-11-26 |
4 |
AS |
$9.00 |
$18,000 |
D/D |
(2,000) |
6,983 |
|
- |
|
| Lovejoy Chandra D |
VP of Regulatory Affairs |
• – – |
2012-11-26 |
4 |
AS |
$8.72 |
$19,262 |
D/D |
(2,209) |
0 |
|
- |
|
| Lovejoy Chandra D |
VP of Regulatory Affairs |
• – – |
2012-11-26 |
4 |
OE |
$2.54 |
$5,611 |
D/D |
2,209 |
1,926 |
|
- |
|
| Ritter Allen R |
VP of Manufacturing/CMC |
• – – |
2012-11-01 |
4 |
AS |
$9.40 |
$47,000 |
D/D |
(5,000) |
8,983 |
|
- |
|
| Lovejoy Chandra D |
VP of Regulatory Affairs |
• – – |
2012-10-25 |
4 |
AS |
$9.71 |
$21,449 |
D/D |
(2,209) |
0 |
|
- |
|
| Lovejoy Chandra D |
VP of Regulatory Affairs |
• – – |
2012-10-25 |
4 |
OE |
$2.54 |
$5,611 |
D/D |
2,209 |
2,209 |
|
- |
|
| Low Philip S |
Chief Science Officer |
• • – |
2012-09-28 |
4 |
S |
$9.99 |
$339,810 |
D/D |
(34,000) |
385,117 |
|
- |
|
| Lovejoy Chandra D |
VP of Regulatory Affairs |
• – – |
2012-09-25 |
4 |
AS |
$10.28 |
$22,709 |
D/D |
(2,209) |
0 |
|
- |
|
| Lovejoy Chandra D |
VP of Regulatory Affairs |
• – – |
2012-09-25 |
4 |
OE |
$2.54 |
$5,611 |
D/D |
2,209 |
2,209 |
|
- |
|
| Leamon Christopher P |
Vice President of Research |
• – – |
2012-08-16 |
4 |
S |
$9.65 |
$96,535 |
D/D |
(10,000) |
15,073 |
|
- |
|
| Hanham Ann |
Director |
– • – |
2012-06-06 |
4 |
S |
$6.60 |
$2,079,379 |
I/I |
(314,900) |
63,940 |
|
- |
|
| Hanham Ann |
Director |
– • – |
2012-06-05 |
4 |
S |
$6.60 |
$67,350 |
I/I |
(10,200) |
88,121 |
|
- |
|
| Hanham Ann |
Director |
– • – |
2012-05-16 |
4 |
S |
$6.65 |
$185,552 |
I/I |
(27,900) |
91,975 |
|
- |
|
| Hanham Ann |
Director |
– • – |
2012-05-15 |
4 |
S |
$6.68 |
$267,148 |
I/I |
(40,000) |
91,046 |
|
- |
|
| Hanham Ann |
Director |
– • – |
2012-05-14 |
4 |
S |
$6.94 |
$742,088 |
I/I |
(107,000) |
94,117 |
|
- |
|
| Low Philip S |
Chief Science Officer |
• • – |
2012-01-20 |
4 |
GD |
$0.00 |
$0 |
D/D |
15,000 |
419,117 |
|
- |
|
| Sanderling Ventures Management Vi |
10% Owner |
– – • |
2011-12-21 |
4/A |
B |
$3.16 |
$5,021 |
I/I |
1,589 |
33,944 |
1.5 |
- |
|
| Ellis P Ron |
President and CEO |
• • – |
2011-12-21 |
5 |
GD |
$0.00 |
$0 |
D/D |
800 |
75,332 |
|
- |
|
| Sanderling Ventures Management Vi |
10% Owner |
– – • |
2011-12-21 |
4 |
B |
$3.16 |
$6,952 |
I/I |
2,200 |
35,166 |
1.5 |
- |
|
| Sanderling V Strategic Exit Fund Lp |
10% Owner |
– – • |
2011-12-21 |
4 |
B |
$3.16 |
$688,248 |
I/I |
217,800 |
871,461 |
1.5 |
- |
|
| Leamon Christopher P |
Vice President of Research |
• – – |
2011-12-21 |
4 |
B |
$3.14 |
$15,700 |
D/D |
5,000 |
25,073 |
2.74 |
- |
|
168 Records found
|
|
Page 5 of 7 |
|
|
